Ashland gave an investor group two board seats and a committee on capital allocation, and put the chief executive on it without a vote

The seats are the headline. The committee is the substance.

Ashland Inc. told the Securities and Exchange Commission on Tuesday that its board had appointed Peter Thomas and Allen Spizzo as independent directors the previous day, effective immediately, with initial terms running to the 2027 annual meeting. Both come out of specialty chemicals. Thomas was chair, chief executive and president of Ferro Corporation until its sale to Prince International in 2022. Spizzo was vice president and chief financial officer of Hercules Incorporated until Ashland bought Hercules in 2008, which makes his return a long loop.

Also on July 27, the board created a Capital Allocation Advisory Committee to make recommendations on how the company deploys its money. It has five voting members: Bertrand Loy, Susan L. Main, Spizzo, Thomas and Scott A. Tozier. Tozier chairs it and Thomas is vice chair. Guillermo Novo, who is both chair of the board and chief executive, is a member without a vote.

That is the concession, and it is more specific than a board seat.

Both moves were made under a cooperation agreement signed the same day with Ancora Holdings Group, LLC and the other persons and entities listed on a schedule to it, together the investor group. In exchange the group accepted voting commitments, customary standstill obligations and mutual non-disparagement. The standstill runs until the earlier of two dates: 30 days before the deadline for stockholders to nominate directors for the 2028 annual meeting, and 110 days before the first anniversary of the 2027 annual meeting. If the board irrevocably offers to renominate Thomas and Spizzo for the 2029 meeting before the standstill lapses, and the group accepts, the whole arrangement rolls forward by a year.

One clause sets a floor rather than a date. If either new director stops serving during the standstill, the investor group may identify a replacement, subject to board and committee approval, only for as long as it has held at least 1.5 percent of the outstanding common stock continuously since the agreement was signed. Neither the report nor the press release states what the group actually holds. The release calls Ancora a meaningful stockholder and leaves it there.

The board arithmetic is temporary by design. Eleven directors now, ten of them independent, falling back to ten immediately before the polls open at the 2027 annual meeting.

Ashland filed its quarterly results a little over an hour after the governance report. Sales in the fiscal third quarter, which ended June 30, were $497 million against $463 million a year earlier, with volumes up 6 percent across every business unit and pricing adding about one percent. Income from continuing operations was $41 million, or $0.89 a diluted share. Net income was $16 million, against a loss of $742 million in the prior-year quarter. Adjusted EBITDA fell 4 percent to $109 million, a 21.9 percent margin, which the company attributes to the carryover from lower production rates earlier in the year, inflation in costs, and incentive compensation returning to normal from a low base.

Sales and adjusted EBITDA guidance for the year is unchanged at $1,835 million to $1,870 million and $385 million to $400 million. The adjusted earnings per share outlook came down, from mid-to-high single-digit growth to low-to-mid, which the company puts on a higher tax rate rather than on the business. Net leverage ended the quarter at 2.4 times.